Show simple item record

dc.contributor.authorBouranis, L
dc.contributor.authorSperrin, M
dc.contributor.authorGreystoke, Alastair
dc.contributor.authorDive, Caroline
dc.contributor.authorRenehan, Andrew G
dc.date.accessioned2013-12-13T15:20:35Z
dc.date.available2013-12-13T15:20:35Z
dc.date.issued2013-10-01
dc.identifier.citationThe interaction between prognostic and pharmacodynamic biomarkers. 2013, 109 (7):1782-5 Br J Canceren
dc.identifier.issn1532-1827
dc.identifier.pmid24002599
dc.identifier.doi10.1038/bjc.2013.527
dc.identifier.urihttp://hdl.handle.net/10541/306822
dc.description.abstractInteractions between prognostic and pharmacodynamic (PD) biomarkers have received little attention.
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titleThe interaction between prognostic and pharmacodynamic biomarkers.en
dc.typeArticleen
dc.contributor.departmentDepartment of Mathematics and Statistics, Fylde College, Lancaster University, Lancaster, UK.en
dc.identifier.journalBritish Journal of Canceren
html.description.abstractInteractions between prognostic and pharmacodynamic (PD) biomarkers have received little attention.


This item appears in the following Collection(s)

Show simple item record